Subacute myelo-optic neuropathy
| Subacute myelo-optic neuropathy | |
|---|---|
| Synonyms | SMON |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Visual impairment, paralysis, numbness |
| Complications | Blindness, paraplegia |
| Onset | Subacute |
| Duration | Chronic |
| Types | N/A |
| Causes | Clioquinol toxicity |
| Risks | Use of clioquinol |
| Diagnosis | Clinical evaluation, neurological examination |
| Differential diagnosis | Multiple sclerosis, neuromyelitis optica |
| Prevention | N/A |
| Treatment | Discontinuation of clioquinol, supportive care |
| Medication | N/A |
| Prognosis | Variable, can lead to permanent disability |
| Frequency | Rare, historically significant in Japan |
| Deaths | N/A |
Subacute Myelo-Optic Neuropathy (SMON) is a rare, toxic disorder that was prevalent in Japan during the 1960s and 1970s. The disease is characterized by subacute onset of sensory and motor disturbances in the lower limbs, visual impairment, and, in some cases, bowel and bladder dysfunction.
Epidemiology[edit]
SMON was first recognized in Japan in the 1960s, where it reached epidemic proportions. The disease affected over 10,000 people in Japan before its cause was identified as the drug clioquinol. After the drug was withdrawn from the market, the incidence of SMON dropped dramatically.
Symptoms[edit]
The symptoms of SMON include sensory and motor disturbances in the lower limbs, visual impairment, and, in some cases, bowel and bladder dysfunction. The onset of symptoms is usually subacute, occurring over a period of days to weeks.
Cause[edit]
The cause of SMON was identified as the drug clioquinol, an antifungal and antiprotozoal medication. Clioquinol was widely used in Japan to treat various intestinal infections. However, it was found to be neurotoxic, leading to the development of SMON in some individuals.
Treatment[edit]
Treatment for SMON is primarily supportive, as there is no cure for the disease. Management of symptoms may include physical therapy for motor disturbances, visual aids for visual impairment, and medications to manage bowel and bladder dysfunction.
See also[edit]
References[edit]
<references />
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


